Skip to content

Treasury Stock at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$222.51M+12.7%
Viatris logo
ViatrisVTRS
$1.01B+48.1%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$10.98M0.0%
Opko Health logo
Opko HealthOPK
$1.79M0.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$10M+32.2%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$43.52B-0.2%

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.7%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's treasury stock?
Scilex Holding Company (SCLX) reported treasury stock of $76.92M in Q1 2026.
How has Scilex Holding Company's treasury stock changed year-over-year?
Scilex Holding Company's treasury stock decreased by 0.0% year-over-year, from $76.92M to $76.92M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.